Associate Director, Downstream Biologics Drug Substance

About Disc Medicine

discmedicine.com

Disc Medicine is a clinical‑stage biopharmaceutical company focused on developing first‑in‑class therapeutics for hematologic disorders. The company harnesses breakthrough science to translate discoveries into medicines designed to disrupt the current standard of care and improve outcomes for patients and families. Its pipeline includes programs in clinical development and the company works closely with patients, healthcare professionals, investors and partners to advance those therapies. Headquartered in Watertown, Massachusetts, Disc Medicine provides medical, investor and partnership contact channels via its website.

Recent company news

MarketBeat

Blue Owl Capital Holdings LP Sells 20,000 Shares of Disc Medicine, Inc. $IRON

14 hours ago

STAT

FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher

3 weeks ago

Reuters

US FDA declines to approve Disc Medicine's rare disease drug

3 weeks ago

Fierce Biotech

FDA rejects Disc's rare disease drug despite commissioner's voucher

3 weeks ago

Yahoo Finance

Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection

6 days ago